Depletion of Langerhans cells following carcinogen treatment is partly due to antigenicity.
Woods
G M
GM
Dept of Pathology, University of Tasmania, Hobart, Australia.
Liew
I H
IH
Muller
H K
HK
D000279:Administration, Cutaneous; D000818:Animals; D000941:Antigens / Q000008:administration & dosage / Q000276:immunology / Q000494:pharmacology*; D002273:Carcinogens / Q000008:administration & dosage / Q000494:pharmacology*; D002452:Cell Count; D002465:Cell Movement / Q000187:drug effects; D017449:Dermatitis, Allergic Contact / Q000276:immunology / Q000473:pathology*; D004817:Epidermis / Q000187:drug effects* / Q000276:immunology / Q000473:pathology; D007801:Langerhans Cells / Q000276:immunology / Q000473:pathology*; D051379:Mice; D008807:Mice, Inbred BALB C / Q000276:immunology
D000941:Antigens; D002273:Carcinogens